# Clinical Trial for GNX80 in Intermittent Claudication

> **NCT05400395** · PHASE4 · UNKNOWN · sponsor: **SK Chemicals Co., Ltd.** · enrollment: 120 (estimated)

## Conditions studied

- Intermittent Claudication

## Interventions

- **DRUG:** GNX80
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05400395
- **Lead sponsor:** SK Chemicals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-05
- **Primary completion:** 2024-03
- **Final completion:** 2024-08
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05400395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05400395, "Clinical Trial for GNX80 in Intermittent Claudication". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05400395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*